Selective intraarterial infusion of vasopressin for control of gastrointestinal bleeding: experience with 35 cases

Long term follow-up of transcatheter coil embolotherapy for major colonic haemorrhage

AIM

Therapeutic angiography with embolization is fast becoming the preferred treatment modality for major bleeding in the lower gastrointestinal (LGI) tract. The aim of this study was to determine the long term outcome and complications of percutaneous coil embolization (PCE) and its efficacy as definitive therapy in patients with major LGI bleeding.

METHODS

All patients presenting to our institution with a haemodynamically significant LGI tract bleed between 1995 and 2001 that were unresponsive to conservative measures were considered for emergency angiography and coil embolization where appropriate. The outcome of these individuals was determined by case note review and telephone interview.

RESULTS

There were 20 patients (11 females) with a mean follow-up period 72 months, mean age was 67 years. All underwent PCE following positive angiogram. The most common site of bleeding was the right colon (40%); haemostasis was successfully achieved in 16 (80%) patients. Five of the 20 patients died within 30 days of the intervention, three following PCE and two following surgery. None of the mortality following PCE was considered procedure related. On long term follow-up four patients required readmission to hospital for further LGI bleeds at 1, 2, 12 and 16 months respectively. Ischaemic complications occurred in 23%.

CONCLUSION

Superselective embolization as the primary technique for the treatment of haemodynamically significant LGI bleeding is an effective, feasible and safe technique. Long term follow-up in our series up to 72 months has shown that it should be considered as both a primary and potentially definitive treatment for life threatening LGI bleeds.

Dual pulse intestinal electrical stimulation normalizes intestinal dysrhythmia and improves symptoms induced by vasopressin in fed state in dogs

To assess effects of dual pulse intestinal electrical stimulation (DPIES) on intestinal dysrhythmia and motility, and symptoms induced by vasopressin in conscious dogs. The study was performed in three postprandial sessions (control; vasopressin; DPIES) in six dogs with two pairs of electrodes chronically implanted on the serosal surface of the proximal jejunum and with a chronic duodenal fistula. A manometric catheter was advanced into the small intestine via the intestinal cannula. Motility and intestinal slow waves were recorded. Symptoms were assessed. During vasopressin infusion, the percentage of normal intestinal slow wave frequency was decreased (P < 0.01), reflected as a significant increase in the percentage of both bradygastria and tachygastria; the motility index decreased (P < 0.01) and the symptom score increased (P < 0.01). In the session of DPIES, the percentage of normal slow wave frequency was recovered (P < 0.05 vs vasopressin), attributed to a reduction in both bradyarrhythmia and tachyarrhythmia; the symptom score was reduced (P < 0.05 vs vasopressin); the motility index was not significantly increased. These results suggest that vasopressin induces intestinal dysrhythmia and emetic symptoms and inhibits intestinal motility. Dual pulse intestinal electrical stimulation is capable of improving intestinal dysrhythmia and emetic symptoms but not impaired intestinal motility induced by vasopressin.

Treatment of lower gastrointestinal bleeding: vasopressin infusion versus embolization

Traditionally, embolization has been reserved for treatment of upper gastrointestinal bleeding whereas lower gastrointestinal (LGI) bleeding has been controlled with vasopressin infusion. This is based on findings in older literature in which infarction frequently complicated LGI embolization. With modern embolization techniques, clinically significant bowel ischemia has become an uncommon complication. Although the efficacies of vasopressin and embolization are fairly comparable, embolotherapy has advantages in terms of quicker completion of therapy and decreased likelihood of systemic complications. Although vasopressin is still probably preferable for diffuse lesions and cases in which superselective catheterization is not technically possible, embolization should be considered a primary option for treating LGI bleeding.

The physiological effects of vasopressin when used to control intra-abdominal bleeding

Vasopressin was used in ten critically ill patients with massive intra-abdominal bleeding unresponsive to conventional therapy. Vasopressin controlled bleeding in four patients, three of whom had continued to bleed following laparotomy for haemostasis; in two other patients, bleeding was reduced. All the patients were intensively monitored throughout the period of the vasopressin treatment; this enabled other physiological effects of vasopressin to be documented and reported. Mean arterial pressure and central venous pressure increased following the administration of vasopressin and there was a decrease in heart rate. Core body temperature rose significantly. Although all the patients had impaired renal function before receiving vasopressin, five had a prompt diuresis following its administration. Eight patients died but only three of intra-abdominal bleeding; two patients survived to leave hospital. Four patients had post-mortem evidence of ischaemia in the heart, liver and gastrointestinal tract; vasopressin may have contributed to the development of this. Vasopressin may have a place in the management of patients with life-threatening intra-abdominal haemorrhage but its use should be confined to those patients in whom conventional therapy has failed.

Small bowel hemorrhage: angiographic localization and intervention

Occult bleeding in the small bowel was localized with mesenteric angiography in 64 patients. Two groups of patients were identified. In the first group comprising 38 patients, bleeding sites were localized by the demonstration of contrast extravasation. In the second group of 26 patients, there was no extravasation. However, other angiographic findings suggested the source of bleeding. No active bleeding was necessary for a positive study in the second group. We conclude that in patients with suspected occult small bowel hemorrhage, mesenteric angiography helps localize the bleeding site. Clinically active bleeding is not always necessary, as angiographic findings other than extravasation may localize the source of hemorrhage.